Achieve Life Sciences, Inc.
Status: Publicly traded
Direct answer
Achieve Life Sciences, Inc. is publicly traded on NASDAQ under the ticker ACHV.
Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and nicotine dependence, with commercial activities spanning Canada, the United States, and the United Kingdom. Cytisinicline is a naturally occurring alkaloid, which functions by engaging with nicotine...
Can you invest in Achieve Life Sciences, Inc.?
Yes. Achieve Life Sciences, Inc. is publicly traded on NASDAQ under the ticker ACHV.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Achieve Life Sciences, Inc.
Detailed equity research is provided by MarketSnap.